MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jnci/djag376

Медицинская библиотека · Journal of the National Cancer Institute · 2026

A new microsimulation model of HPV natural history for comparison of novel cervical screening strategies.

Campos Nicole G, Cheung Li C, Mao Fangya, Befano Brian, Egemen Didem, Sy Stephen, Kim Jane J, Wentzensen Nicolas, Desai Kanan, de Sanjosé Silvia, Schiffman Mark

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The cost-effectiveness of cervical cancer screening strategies is estimated by health decision models. Fidelity to HPV natural history and multi-state carcinogenesis is critical to improve evaluations of new screening tests.

METHODS

We developed a new health decision model of the HPV genotype-specific causal pathway to cervical cancer based on cohort, trial, and cross-sectional data. The novel model presents several new approaches in representing early HPV natural history: 1) transitions between health states are estimated by new statistical approaches adapted to handle intermittently-observed data; 2) transitions are directly estimated from observational data (i.e., statistically identifiable) rather than calibrated to fit; and 3) precancer is rigorously defined using histopathology and HPV genotyping as a surrogate for cancer risk.

RESULTS

We present a model for pending policy decisions in Brazil. Model outputs closely match age-specific prevalence data from São Paulo for thirteen carcinogenic HPV types 16/18/31/33/35/45/52/58 (modeled individually) and 39/51/56/59/68 (grouped). The model-projected median age of precancer is 30.0 years (95% CI: 27.9-32.3 years).

CONCLUSIONS

By restricting model health states and transitions to the essential, directly observable causal pathway, our approach can generate metrics with measurable standard errors for cost-effectiveness analyses. Comparative modeling analyses are underway to assess differences in results relative to existing state-of-the-art models. Our approach can be generalized to evaluate the cost-effectiveness of an HPV-based screen-triage-treat approach with extended genotyping that has been demonstrated efficacious in nine PAVE Consortium countries.

Для цитирования: Campos Nicole G, Cheung Li C, Mao Fangya, Befano Brian, Egemen Didem, Sy Stephen, Kim Jane J, Wentzensen Nicolas, Desai Kanan, de Sanjosé Silvia, Schiffman Mark. A new microsimulation model of HPV natural history for comparison of novel cervical screening strategies.. Journal of the National Cancer Institute. 2026. DOI: 10.1093/jnci/djag376.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.